Opioid Use Disorder Market Updates 2024 : Predicted to Reach USD 8.1 Billion by 2031; at a Notable CAGR of 11.5% from 2022 to 2031

According to a new report published by Allied Market Research, titled, “Opioid Use Disorder Market,” The opioid use disorder market size was valued at $2.8 billion in 2021, and is estimated to reach $8.1 billion by 2031, growing at a CAGR of 11.5% from 2022 to 2031.

Opioids, whether produced synthetically or naturally, are designed in laboratories to replicate the chemical properties of natural opioids. These substances interact with opioid receptors on nerve cells in the body and brain, effectively alleviating pain. The opioid category includes heroin, synthetic opioids, and prescription painkillers. Prescription opioids are intended for managing acute pain, such as after an injury or surgery, as well as chronic pain, active cancer treatment, palliative care, and end-of-life care. Many patients depend on prescribed opioids to manage their medical conditions. However, opioid use disorder is a chronic, lifelong condition with serious potential consequences, including disability, relapses, and death.

Request Sample of the Report on Opioid Use Disorder Market Forecast 2031– https://www.alliedmarketresearch.com/request-sample/A12303

How Opioid Use Disorder Market is Segmented ?

The global opioids use disorder market is analyzed by drug type, age group, route of administration, distribution channel, and region. The report provides a thorough analysis of these segments and their sub-segments using both tabular and graphical representations. Investors and market players can utilize this detailed breakdown to formulate strategies based on the highest revenue-generating and fastest-growing segments highlighted in the report.

• Drug Type: The agonist segment accounted for more than four-fifths of the global opioids use disorder market in 2021 and is projected to dominate by 2031. This segment is also expected to exhibit the fastest CAGR of 11.6% throughout the forecast period.
• Age Group: The 19 to 39 age group segment held nearly half of the total market revenue in 2021 and is anticipated to dominate by 2031. This segment is also projected to have the fastest CAGR of 11.9% throughout the forecast period.
• Route of Administration: The intravenous segment accounted for more than half of the total market revenue in 2021 and is expected to continue its dominance by 2031. This segment is also anticipated to record the fastest CAGR of 11.9% throughout the forecast period.
• Distribution Channel: The hospital pharmacy segment represented nearly three-fourths of the total market revenue in 2021 and is expected to maintain its dominance by 2031. This segment is also forecasted to achieve the fastest CAGR of 11.6% throughout the forecast period.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the opioid use disorder market analysis from 2021 to 2031 to identify the prevailing opioid use disorder market opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the opioid use disorder market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global opioid use disorder market trends, key players, market segments, application areas, and market growth strategies.

Key Findings Of The Study
•    By type, the agonist segment was the highest contributor to the market in 2021.
•    By age group, the 19 to 39 segment was the highest contributor to the market in 2021.
•    By route of administration, the intravenous segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
•    By distribution channel, the hospital pharmacy segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
•    By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/12668

Regional Trends

Based on region, North America generated nearly two-fifths of the global opioids use disorder market revenue in 2021 and is expected to retain the largest share by 2031. Conversely, the Asia-Pacific region is projected to exhibit the fastest CAGR of 12.3% during the forecast period. The report also includes analysis of the LAMEA and Europe regions.

Key Opioid Use Disorder Market Companies

• AstraZeneca Plc.
• BioDelivery Sciences International Inc.
• Braeburn
• Cerebral
• Hikma Pharmaceuticals PLC
• NYC Health + Hospitals
• Dr. Reddy
• Indivior PLC
• Mallinckrodt Pharmaceuticals
• Alkermes
• Orexo AB
• Camurus
• Pear Therapeutics
• Pfizer
• Reckitt Benckiser Pharmaceuticals Inc.
• Sandoz (Novartis)
• Viatris Inc.
• Titan Pharmaceuticals, Inc.

Trending Reports in Healthcare Industry-

Skin Antiseptic Market https://www.alliedmarketresearch.com/skin-antiseptic-market-A12682

Blood Pressure Cuffs Market https://www.alliedmarketresearch.com/blood-pressure-cuffs-market-A11934

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports Insights” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa

1209 Orange Street, Corporation Trust Center, Wilmington, New Castle, Delaware 19801 USA.

Int’l: +1-503-894-6022 Toll Free: +1-800-792-5285

UK: +44-845-528-1300

India (Pune): +91-20-66346060 Fax: +1-800-792-5285 help@alliedmarketresearch.com